When I was diagnosed with multiple sclerosis in 1999, there were three “disease-modifying therapies” (DMTs) available to treat multiple sclerosis. Now there are more than ten pharmaceutical drug options on the market for people diagnosed with MS to try in the hopes of slowing down the progression and minimizing the severity of the course of […]